Possible CDK4/6 inhibitor use in betel-nuts related head and neck squamous cell carcinoma(HNSCC).

被引:0
|
作者
Chen, Jo-Pai
Chang, Jui-Ying
Kuo, Sung Hsin
Hong, Ruey-Long
机构
[1] Natl Taiwan Univ Hosp, Yu Lin Branch, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[4] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
关键词
D O I
10.1200/JCO.2018.36.15_suppl.e18030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18030
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
    Dong, Lin
    Liu, Chao
    Sun, Haoyang
    Wang, Mo
    Sun, Mengyu
    Zheng, Jianwei
    Yu, Xiaoxue
    Shi, Rong
    Wang, Bo
    Zhou, Qianqian
    Chen, Zhiqiang
    Xing, Bofan
    Wang, Yu
    Yao, Xiaofeng
    Mei, Mei
    Ren, Yu
    Zhou, Xuan
    CANCER LETTERS, 2024, 593
  • [22] Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas
    Gottgens, Eva-Leonne
    Bussink, Johan
    Leszczynska, Katarzyna B.
    Peters, Hans
    Span, Paul N.
    Hammond, Ester M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (03): : 548 - 558
  • [23] CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck
    Billard-Sandu, Camelia
    Tao, Yun-Gan
    Sablin, Marie-Paule
    Dumitrescu, Gabriela
    Billard, David
    Deutsch, Eric
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (05) : 1273 - 1280
  • [24] CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck
    Camelia Billard-Sandu
    Yun-Gan Tao
    Marie-Paule Sablin
    Gabriela Dumitrescu
    David Billard
    Eric Deutsch
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 1273 - 1280
  • [25] Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring
    Chaudhary, Sanjib
    Pothuraju, Ramesh
    Rachagani, Satyanarayana
    Siddiqui, Jawed A.
    Atri, Pranita
    Mallya, Kavita
    Nasser, Mohd W.
    Sayed, Zafar
    Lyden, Elizabeth R.
    Smith, Lynette
    Gupta, Siddhartha D.
    Ralhan, Ranju
    Lakshmanan, Imayavaramban
    Jones, Dwight T.
    Ganti, Apar Kishor
    Macha, Muzafar A.
    Batra, Surinder K.
    CANCER LETTERS, 2021, 510 : 79 - 92
  • [26] Expression of cdk6 in head and neck squamous cell carcinoma
    Sopee Poomsawat
    Sirima Sanguansin
    Jirapa Punyasingh
    Paisarn Vejchapipat
    Phaibul Punyarit
    Clinical Oral Investigations, 2016, 20 : 57 - 63
  • [27] Expression of cdk6 in head and neck squamous cell carcinoma
    Poomsawat, Sopee
    Sanguansin, Sirima
    Punyasingh, Jirapa
    Vejchapipat, Paisarn
    Punyarit, Phaibul
    CLINICAL ORAL INVESTIGATIONS, 2016, 20 (01) : 57 - 63
  • [28] The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
    Wang, Che-Wei
    Biswas, Pulak Kumar
    Islam, Atikul
    Chen, Mu-Kuan
    Chueh, Pin Ju
    CELLS, 2024, 13 (05)
  • [29] Preclinical head-to-head comparison of CDK4/6 inhibitor activity toward CDK4 vs CDK6
    Delach, Scott
    Caponigro, Giordano
    CANCER RESEARCH, 2021, 81 (04)
  • [30] CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas
    Duah, Ernest
    Seligson, Nathan D.
    Persaud, Avinash K.
    Dam, Quynh
    Pabla, Navjot
    Rocco, James W.
    Li, Junan
    Poi, Ming
    MOLECULAR CARCINOGENESIS, 2023, 62 (08) : 1201 - 1212